{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:46:41Z","timestamp":1788306401054,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004371","name":"School of Health Sciences, University of Tampere","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004371","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Health"},{"name":"National Programme of Antibiotic Protection"},{"name":"Ministry of Science and Higher Education"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.vaccine.2018.12.028","type":"journal-article","created":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T08:53:44Z","timestamp":1547024024000},"page":"1365-1373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pneumococcal meningitis before the introduction of 10-valent pneumococcal conjugate vaccine into the National Childhood Immunization Program in Poland"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0148-7183","authenticated-orcid":false,"given":"Aleksandra","family":"Polkowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Skoczy\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Paradowska-Stankiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"Stefanoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleria","family":"Hryniewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicja","family":"Kuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Outi","family":"Lyytik\u00e4inen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Pekka","family":"Nuorti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.12.028_b0005","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1128\/CMR.00070-09","article-title":"Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis","volume":"23","author":"Brouwer","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2018.12.028_b0010","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates","volume":"374","author":"O\u2019Brien","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2018.12.028_b0015","first-page":"1","article-title":"Community-acquired bacterial meningitis in adults in the Netherlands, 2006\u201314: a prospective cohort study","volume":"3099","author":"Bijlsma","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2018.12.028_b0020","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S1473-3099(14)70805-9","article-title":"Epidemiology of bacterial meningitis in the USA from 1997 to 2010: a population-based observational study","volume":"14","author":"Castelblanco","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2018.12.028_b0025","first-page":"557","article-title":"Pathogenesis and pathophysiology of pneumococcal meningitis","volume":"24","author":"Mook-Kanamori","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2018.12.028_b0030","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1473-3099(10)70048-7","article-title":"Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis","volume":"10","author":"Edmond","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2018.12.028_b0035","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40478-016-0297-4","article-title":"Pneumococcal meningitis: clinical-pathological correlations (meningene-path)","volume":"4","author":"Engelen-Lee","year":"2016","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.vaccine.2018.12.028_b0040","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0140-6736(00)04222-7","article-title":"Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children","volume":"357","author":"Hausdorff","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2018.12.028_b0045","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1080\/00365540801938931","article-title":"Trends and geographical variation in invasive pneumococcal infections in Finland","volume":"40","author":"Klemets","year":"2008","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.12.028_b0050","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1086\/587897","article-title":"Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States","volume":"46","author":"Tsai","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2018.12.028_b0055","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s12325-013-0051-2","article-title":"A review of the impact of pneumococcal polysaccharide conjugate vaccine (7-valent) on pneumococcal meningitis","volume":"30","author":"Htar","year":"2013","journal-title":"Adv Ther"},{"key":"10.1016\/j.vaccine.2018.12.028_b0060","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1097\/INF.0000000000000451","article-title":"Trends of pneumococcal meningitis in children after introduction of the 13-valent pneumococcal conjugate vaccine in France","volume":"33","author":"Levy","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2018.12.028_b0065","doi-asserted-by":"crossref","first-page":"e015080","DOI":"10.1136\/bmjopen-2016-015080","article-title":"Bacterial meningitis in Finland, 1995\u20132014: a population-based observational study","volume":"0","author":"Polkowska","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2018.12.028_b0070","unstructured":"Schrag SJ, Beall B, Dowell S. & World Health Organization. Communicable Diseases Cluster. (2001). Resistant pneumococcal infections: the burden of disease and challenges in monitoring and controlling antimicrobial resistance https:\/\/www.who.int\/iris\/handle\/10665\/66846."},{"key":"10.1016\/j.vaccine.2018.12.028_b0075","unstructured":"European Centre for Disease Prevention and Control. Surveillance of antimicrobial resistance in Europe 2016. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC; 2017."},{"key":"10.1016\/j.vaccine.2018.12.028_b0080","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1469-0691.2010.03182.x","article-title":"Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period","volume":"16","author":"Li\u00f1ares","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2018.12.028_b0085","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1469-0691.2009.02724.x","article-title":"The antimicrobial resistance profile of Streptococcus pneumoniae","volume":"15","author":"Reinert","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2018.12.028_b0090","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1128\/AAC.05658-11","article-title":"Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: An Asian Network for Surveillance of Resistant Pathogens (ANSORP) study","volume":"56","author":"Kim","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2018.12.028_b0095","unstructured":"Czarkowski MP, Kondej B, Staszewska-Jakubik E, Cieleb\u0105k E. Vaccinations in Poland in 2015. National Institute of Public Health- National Institute of Hygiene and Chief Sanitary Inspectorate, Warsaw, 2016."},{"key":"10.1016\/j.vaccine.2018.12.028_b0100","unstructured":"Commission Decision of 19 March 2002 laying down case definitions for reporting communicable diseases to the Community network under Decision No 2119\/98\/EC of the European Parliament and of the Council (2002\/253\/EC)."},{"key":"10.1016\/j.vaccine.2018.12.028_b0105","doi-asserted-by":"crossref","first-page":"6192","DOI":"10.1128\/IAI.71.11.6192-6198.2003","article-title":"Genetic basis for the structural difference between Streptococcus pneumoniae serotype 15B and 15C capsular polysaccharides","volume":"71","author":"van Selm","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.12.028_b0110","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/163688a0","article-title":"Measurement of diversity","volume":"163","author":"Simpson","year":"1949","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2018.12.028_b0115","doi-asserted-by":"crossref","first-page":"6232","DOI":"10.1016\/j.vaccine.2013.10.032","article-title":"Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway","volume":"31","author":"Steens","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.12.028_b0120","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/BF02140530","article-title":"die agglutina der pneumokokken und uber die theorien der agglutination","volume":"40","author":"Uber","year":"1902","journal-title":"Z. Hyg. Infekt-Kr"},{"key":"10.1016\/j.vaccine.2018.12.028_b0125","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 5.0 2015."},{"key":"10.1016\/j.vaccine.2018.12.028_b0130","unstructured":"Prawo farmaceutyczne z dnia 6 wrze\u015bnia 2001 r. (Dz. U. Nr 126, poz. 138 z p\u00f3\u017an. zm.)"},{"key":"10.1016\/j.vaccine.2018.12.028_b0135","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/j.vaccine.2010.09.100","article-title":"The current status of invasive pneumococcal disease in Poland","volume":"29","author":"Skoczy\u0144ska","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.12.028_b0140","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s10096-014-2283-8","article-title":"Recent trends in epidemiology of invasive pneumococcal disease in Poland","volume":"34","author":"Skoczy\u0144ska","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2018.12.028_b0145","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1471-2334-8-96","article-title":"Invasive pneumococcal infections among persons with and without underlying medical conditions: implications for prevention strategies","volume":"8","author":"Klemets","year":"2008","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2018.12.028_b0150","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.vaccine.2015.12.066","article-title":"Invasive pneumococcal disease: clinical outcomes and patient characteristics 2\u20136 years after introduction of 7-valent pneumococcal conjugate vaccine compared to the pre-vaccine period, the Netherlands","volume":"34","author":"Wagenvoort","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.12.028_b0155","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1651-2227.2000.tb00776.x","article-title":"Epidemiology of invasive and other pneumococcal disease in children in England and Wales 1996\u20131998","volume":"89","author":"Miller","year":"2000","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/j.vaccine.2018.12.028_b0160","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/jac\/dkh211","article-title":"Prospective surveillance of incidence, serotypes and antimicrobial susceptibility of invasive Streptococcus pneumoniae among hospitalized children in Austria","volume":"53","author":"Rendi-Wagner","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.vaccine.2018.12.028_b0165","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s10096-008-0512-8","article-title":"Invasive pneumococcal disease in children up to 5 years of age in Poland","volume":"27","author":"Grzesiowski","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2018.12.028_b0170","series-title":"Rekomendacje post\u0119powania w zaka\u017ceniach bakteryjnych o\u015brodkowego uk\u0142adu nerwowego","author":"Albrecht","year":"2011"},{"key":"10.1016\/j.vaccine.2018.12.028_b0175","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1016\/j.vaccine.2010.03.069","article-title":"Surveillance of invasive pneumococcal disease in 30 EU countries: Towards a European system?","volume":"28","author":"Hanquet","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.12.028_b0180","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1086\/313609","article-title":"The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II","volume":"30","author":"Hausdorff","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2018.12.028_b0185","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1473-3099(05)70083-9","article-title":"Epidemiological differences among pneumococcal serotypes","volume":"5","author":"Hausdorff","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2018.12.028_b0190","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1086\/313608","article-title":"Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I","volume":"30","author":"Hausdorff","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2018.12.028_b0195","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.vaccine.2014.02.096","article-title":"Differences in serious clinical outcomes of infection caused by specific pneumococcal serotypes among adults","volume":"32","author":"Grabenstein","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.12.028_b0200","doi-asserted-by":"crossref","first-page":"e1000081","DOI":"10.1371\/journal.pmed.1000081","article-title":"Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study","volume":"6","author":"Harboe","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2018.12.028_b0205","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1080\/14760584.2017.1362339","article-title":"Streptococcus pneumoniae serotype 19A: worldwide epidemiology","volume":"16","author":"Isturiz","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2018.12.028_b0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-015-0787-1","article-title":"Pneumococcal meningitis and vaccine effects in the era of conjugate vaccination: results of 20 years of nationwide surveillance in Germany","volume":"15","author":"Im\u00f6hl","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2018.12.028_b0215","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12916-016-0755-7","article-title":"Impact of pneumococcal conjugate vaccines on pneumococcal meningitis cases in France between 2001 and 2014: a time series analysis","volume":"14","author":"Alari","year":"2016","journal-title":"BMC Med"},{"key":"10.1016\/j.vaccine.2018.12.028_b0220","unstructured":"European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2015. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). 2017. doi:10.2900\/39777."},{"key":"10.1016\/j.vaccine.2018.12.028_b0225","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1469-0691.2009.02726.x","article-title":"Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae","volume":"15","author":"Dagan","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2018.12.028_b0230","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s10096-017-3033-5","article-title":"Streptococcus pneumoniae antimicrobial resistance decreased in the Helsinki Metropolitan Area after routine 10-valent pneumococcal conjugate vaccination of infants in Finland","volume":"36","author":"Sihvonen","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2018.12.028_b0235","doi-asserted-by":"crossref","first-page":"6484","DOI":"10.1128\/AAC.03344-14","article-title":"Changes in pneumococcal serotypes and antimicrobial resistance after introduction of the 13-valent conjugate vaccine in the United States","volume":"58","author":"Richter","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2018.12.028_b0240","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1471-2334-11-323","article-title":"Clinical outcome of pneumococcal meningitis during the emergence of pencillin-resistant Streptococcus pneumoniae: An observational study","volume":"11","author":"Gouveia","year":"2011","journal-title":"BMC Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18317018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18317018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T23:39:51Z","timestamp":1565221191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18317018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0264410X18317018"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.12.028","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pneumococcal meningitis before the introduction of 10-valent pneumococcal conjugate vaccine into the National Childhood Immunization Program in Poland","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.12.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}